22 results
8-K
EX-1.1
MRSN
Mersana Therapeutics Inc
28 Feb 24
Entry into a Material Definitive Agreement
4:08pm
and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act.
(l) Financial Statements. The financial statements
8-K
EX-1.1
5zjolq7fx 2mlm6bv
7 Nov 22
Entry into a Material Definitive Agreement
4:05pm
PRE 14A
2u1xxukyeyo
18 Apr 22
Preliminary proxy
4:10pm
8-K
EX-1.1
i4d9htitxx62o stqm6
28 Feb 22
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-1.1
hjxppiguep6e2ukr
1 Jun 20
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-1.1
k5sf dg0ngp79qo18c
4 Mar 19
Entry into a Material Definitive Agreement
4:54pm
S-3
EX-1.2
xkeabuzowx9hktv7
2 Jul 18
Shelf registration
5:27pm